Cite
Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation.
MLA
Andrieu, M., et al. “Endocytosis of an HIV-Derived Lipopeptide into Human Dendritic Cells Followed by Class I-Restricted CD8(+) T Lymphocyte Activation.” European Journal of Immunology, vol. 30, no. 11, Nov. 2000, pp. 3256–65. EBSCOhost, https://doi.org/10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H.
APA
Andrieu, M., Loing, E., Desoutter, J. F., Connan, F., Choppin, J., Gras-Masse, H., Hanau, D., Dautry-Varsat, A., Guillet, J. G., & Hosmalin, A. (2000). Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation. European Journal of Immunology, 30(11), 3256–3265. https://doi.org/10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H
Chicago
Andrieu, M, E Loing, J F Desoutter, F Connan, J Choppin, H Gras-Masse, D Hanau, A Dautry-Varsat, J G Guillet, and A Hosmalin. 2000. “Endocytosis of an HIV-Derived Lipopeptide into Human Dendritic Cells Followed by Class I-Restricted CD8(+) T Lymphocyte Activation.” European Journal of Immunology 30 (11): 3256–65. doi:10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H.